News

Texas Sues Eli Lilly Over Bribery Allegations

Texas sues Eli Lilly for allegedly bribing providers to prescribe its medications
WASHINGTON (Reuters) -Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly "bribing" providers to prescribe its medications. The attorney general's office said in a statement that the company bribed and illegally induced medical providers to prescribe its most profitable drugs,
Texas sues Eli Lilly for allegedly bribing providers to push weight loss medications
Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its medications.
Texas Sues Eli Lilly Over Bribery Allegations: Retail Focuses On Company’s Upbeat Performance
Texas Attorney General Ken Paxton alleged that Lilly offered illegal incentives to medical providers in Texas designed to steer providers toward prescribing Lilly’s drugs.
Eli Lilly closer to breakthrough weight loss drug; shares tumble as some question results
Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial saw people lose 12% of body weight.
Initial results show promise for Eli Lilly's new weight loss drug
Orforglipron, the new weight loss pill manufactured by Eli Lilly, helped patients in a recent study lose a significant amount of weight, the company said.
Eli Lilly weight loss pill shows promise in latest clinical trial, company says
In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.
Eli Lilly sued in Texas over illegal kickbacks related to weight loss drugs
Eli Lilly (LLY) stock in focus as Texas sues the company for alleged bribery related to weight loss drugs like Zepbound and its other medications. Read more here.
Eli Lilly: The Bears Have Spoken Loud And Clear (Upgrade)
Eli Lilly and Company faces valuation pressure after disappointing Orforglipron results. Discover why now isn't the time to ...
24/7 Wall St.8h
Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (Aug 2025)
Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.
1 Reason to Buy Eli Lilly (LLY) Stock
Its shares aren't exactly cheap at recent levels, though.
Experimental GLP-1 pill helped people with obesity lose weight, Eli Lilly says
In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...
Eli Lilly and GSK drive South Korea’s drug licensing activity
South Korea’s pharma industry has a valuable pool of promising drugs, but China still leads the way in out-licensing deals.
Eli Lilly could afford its Wisconsin project without our tax dollars | Letters
Eli Lilly had profit of $10 billion in 2024. It could afford its Wisconsin project without Evers' $100 million tax credits ...
Eli Lilly Shares Plummet 14% Toward Worst Day In 25 Years—Here’s Why It’s Down
Eli Lilly on Thursday released data for its daily obesity pill, orforglipron, which found the medication helped obese or ...
Hosted on MSN4h
Is Eli Lilly a Buy? Analyst Confidence Grows for 2025
Eli Lilly's (NYSE: LLY) market isn't out of the weeds yet but will rebound strongly in 2025. The Q3 results failed to spark ...